Latest research news are now in your pocket

Monday, 10 October 2016

IDENTITY CRISIS: BRAIN CANCER CELL LINE WIDELY USED MIGHT NOT BE THE ORIGINAL ONE.

Bengt Westermark and colleagues have asserted that the cell line considered to be the most commonly used in brain cancer research is different from the original patient tumor from which it was derived. They were the first to establish the cell line almost 50 years ago. According to the authors, the publicly available cell line, which has been used in more than 1,700 publications, appears to be a type of glioma cell line, likely a glioblastoma, of unknown origin.
This particular case of mistaken identity, among others, shines a spotlight on misidentification or contamination of cell lines as a long-standing quality-control issue that imperils the reproducibility of scientific experiments and the overall field of translational research. In 1968, Westermark and his team established U87MG, a glioma cell line that has since been made available commercially in repositories, such as the American Type Culture Collection (ATCC). The authors suspect that U87MG is the most popular cell line created, with roughly 200 studies published in 2015 alone.
Using forensic and mitochondrial DNA profiling to trace U87MG's origin, Westermark and his colleague questions the authenticity of the cell line. This analysis revealed that the origin of the cell line is different from that of the original tumor, pointing to a potential cross-contamination. The researchers also looked at the genetic signature of U87MG, comparing its similarity to a large database of cancer cell lines. Results confirmed that the cells originated from the Central Nervous System (CNS).  These finding has brought to the forefront need to authenticate cell lines in order to produce more consistent scientific research. To address this important issue, authors call on the research community to move away from "classical" cell lines like U87MG in favor of verified glioma cell lines grown in proper conditions, which tend to be more representative of the tumor of origin.


Source: Science Translational Medicine
Share:

0 comments:

Post a Comment

Copyright © We The Microbiologist Research News | Powered by Blogger
Design by SimpleWpThemes | Blogger Theme by NewBloggerThemes.com